LyGenesis procures $3 mln Series A
Pittsburgh-based LyGenesis Inc, a biotechnology company developing technology for organ regeneration, has raised $3 million in Series A financing. The investor was Juvenescence Ltd.
9 May 2018•1 min read
Pittsburgh-based LyGenesis Inc, a biotechnology company developing technology for organ regeneration, has raised $3 million in Series A financing. The investor was Juvenescence Ltd.
